TherapeuticsMD TXMD
NASDAQ TXMD
$1.80 -0.05 (-2.70%)
At close: Oct 23, 2026 · 4:00 PM EDT

TherapeuticsMD (TXMD) Asset Writedowns and Impairment (2019 - 2025)

Updated

TherapeuticsMD (TXMD) recorded Asset Writedowns and Impairment of $1.26 million in Q1 2025.

Analysis

TherapeuticsMD (TXMD) Asset Writedowns and Impairment (2019 - 2025) Analysis & Trends

On a TTM basis, TherapeuticsMD's Asset Writedowns and Impairment came in at $1.27 million as of Mar 31, 2025; for FY2024, it was $1.27 million.

  • Annual Asset Writedowns and Impairment has a five-year compound annual growth rate of 66.2% (FY2019 to FY2024).
  • Across earlier years, Asset Writedowns and Impairment came in at $1.13 million in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn
10 TherapeuticsMD 20.83 Mn 20.83 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 1.26 Mn
Dec 31, 2024 7,000.00
Mar 31, 2023 59,000.00
Dec 31, 2020 500,000.00
Sep 30, 2020 600,000.00
Dec 31, 2019 21,136.00
API Access

TherapeuticsMD Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=TXMD&period=max&api_key=YOUR_API_KEY